Tag:

Vivotif

Latest Headlines

Latest Headlines

PaxVax expands commercial network for typhoid vaccine

April 23, 2015 | By
PaxVax's typhoid vaccine, Vivotif, is licensed for sale in 27 countries. But the Redwood, CA-based company is looking to expand its presence, announcing on Wednesday a series of commercial partnerships and distribution agreements to ensure availability of Vivotif in Australia and Europe.

PaxVax ready to strike M&A; deals that prove its sales model, CEO says

January 15, 2015 | By
PaxVax entered the M&A; arena last summer, nabbing typhoid vaccine Vivotif from Johnson & Johnson subsidiary Crucell. And it's not stopping there, CEO Ken Kelley says.
Related Tags
Press Releases
  • Opening Arguments Today in Largest US Pharma Theft Civil Suit
  • Award of Funding for Next Stage of US Department of Defense Programme to Develop Genedrive® Biohazard Identification Tests
  • Men in England to finally have routine access to UK-discovered prostate cancer medicine Zytiga (abiraterone acetate) before chemotherapy
  • Switching to Remsima®▼ (infliximab) from originator has no negative effect on safety or efficacy in 10 real-world studies
  • The Myriad myRisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
  • More Press Releases
Sponsored Links